FADS1 encodes a desaturase enzyme critical for converting plant-based omega-3 (ALA) into EPA and DHA. During menopause, estrogen decline alters lipid metabolism and inflammation. A common myth is that specific FADS1 variants directly cause hot flashes or weight gain. In reality, no strong human studies confirm a causal link between FADS1 polymorphisms and menopause symptoms. Current evidence is mostly mechanistic or from animal models. The fact is: FADS1 activity varies genetically, but its clinical impact on menopause remains unclear. High-dose omega-3 supplements are often marketed for symptom relief, yet evidence for efficacy is weak and inconsistent. Safety note: excessive omega-3 intake may increase bleeding risk, especially if combined with anticoagulants. A balanced diet rich in ALA sources (flaxseed, walnuts) and occasional fatty fish is sensible, but genetic test results alone should not dictate supplementation. Consumer DNA tests overstate predictive power; most menopause outcomes are multifactorial. Evidence: mechanistic/unclear.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-457498fd243ab1b264bc9415